NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with multiple sclerosis. NICE has said Biogen's Tysabri can now be used by the NHS ...
Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad, reducing their need for clinic visits. New guidance (PDF) from health ...
Mar. 18, 2026 Your morning coffee or tea could be quietly supporting your brain health. A long-term study found that moderate consumption of caffeinated coffee or tea was linked to an 18% lower risk ...
How Americans use their time looks different for older and younger adults. And across age groups, it differs by gender. Using data from the American Time Use Survey, we explore how daily time use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results